Lanean...
Late Cardiotoxicity in MS Patients Treated with Mitoxantrone
CONTEXT: Mitoxantrone (MTX) is an antracyclin drug that is used for treatment of patients with chronic refractory multiple sclerosis (MS). Congestive heart failure (CHF) is a rare complication of this drug that may occur early, during therapy, or late, months or years after termination of therapy. A...
Gorde:
| Argitaratua izan da: | Int J Prev Med |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wolters Kluwer - Medknow
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6941302/ https://ncbi.nlm.nih.gov/pubmed/31921403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijpvm.IJPVM_477_17 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|